Nathan Brand, MD

Title(s)RESIDENT PHYSICIAN, Surgery
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Colorado CollegeBAPhilosophy
    Columbia UniversityM.D MSc

    Collapse Overview 
    Collapse Overview
    Nathan Brand M.D MSc is currently a general surgery resident at UCSF. He obtained his B.A at Colorado College where he majored in philosophy. Following his graduation he worked for the NIH as a Cancer Research Training Award Fellow in the Laboratory for Translation Genomics. He then traveled to Malawi and Uganda where he spent a year volunteering in a rural clinic and working for the University of Minnesota researching pediatric severe malaria.

    Dr. Brand attended medical school at Columbia University where he obtained both a M.D and a MSc in global health. During this time he also worked for the Center for Global Health at the US National Cancer Institute and spent a year working as the Cancer Control Consultant to Kenya.

    During his time at UCSF, Dr. Brand has focused his research on both global health and surgical oncology. He is currently in the lab working for Dr. David Jablons on identifying novel therapeutics for esophageal squamous cell carcinoma. His work is supported by both the Surgical Oncology T32 and the Thoracic Surgery Society's Resident Research Award.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. IFN-?4 is associated with increased risk and earlier occurrence of several common infections in African children. Genes Immun. 2021 05; 22(1):44-55. Prokunina-Olsson L, Morrison RD, Obajemu A, Mahamar A, Kim S, Attaher O, Florez-Vargas O, Sidibe Y, Onabajo OO, Hutchinson AA, Manning M, Kwan J, Brand N, Dicko A, Fried M, Albert PS, Mbulaiteye SM, Duffy PE. PMID: 33850301.
      View in: PubMed   Mentions:    Fields:    
    2. Moving towards an evidence-informed cancer control strategy: A scoping review of oncology research in Kenya. Journal of Cancer Policy. 2020; 24. Veronica Manduku, Mina Akhavan, Gershim Asiki, Nathan R. Brand, Mishka K. Cira, Zeinab Gura, Damazo T. Kadengye, Alfred Karagu, Alicia A. Livinski, Helen Meme, Catherine Kyobutungi. View Publication.
    3. Interventions Addressing Barriers to Delayed Cancer Diagnosis in Low- and Middle-Income Countries: A Systematic Review. Oncologist. 2020 09; 25(9):e1382-e1395. Qu LG, Brand NR, Chao A, Ilbawi AM. PMID: 32125732.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review. Oncologist. 2019 12; 24(12):e1371-e1380. Brand NR, Qu LG, Chao A, Ilbawi AM. PMID: 31387949.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    5. Knowledge Summaries for Comprehensive Breast Cancer Control: Feedback From Target Audiences in Kenya. J Glob Oncol. 2019 01; 5:1-6. Cira MK, Zujewski JA, Dvaladze A, Brand NR, Vogel AL. PMID: 30689495.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts. Journal of Cancer Policy. 2018. C. Morgan, M. Cira, A. Karagu, F.C Asirwa, N.R Brand, N.Buchanan Lunsford, S.M Dawsey, A.Galassi, A.Korir, L. Kupfer, P.J Loehrer, D. Makumi, L.Muchiri, S. Sayed, H. Topazian, J. Welch, M.J Williams, K. Duncan. View Publication.
    7. Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions. Lancet. 2018 05 12; 391(10133):1939-1952. Sayed S, Cherniak W, Lawler M, Tan SY, El Sadr W, Wolf N, Silkensen S, Brand N, Looi LM, Pai SA, Wilson ML, Milner D, Flanigan J, Fleming KA. PMID: 29550027.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    8. Histology and Cytopathology Capacity in the Public Health Sector in Kenya. J Glob Oncol. 2018 09; 4:1-7. Brand NR, Wolf N, Flanigan J, Njoroge R, Karagu A. PMID: 30241145.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. Sentinel Lymph Node Biopsy Pathology and 2-Year Postsurgical Recurrence of Breast Cancer in Kenyan Women. J Glob Oncol. 2018 09; 4:1-7. Brand NR, Wasike R, Makhdomi K, Chauhan R, Moloo Z, Gakinya SM, Neugut AI, Zujewski JA, Sayed S. PMID: 30241138.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria. J Pediatric Infect Dis Soc. 2017 Sep 01; 6(3):e41-e48. Opoka RO, Hamre KES, Brand N, Bangirana P, Idro R, John CC. PMID: 28339598.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    11. Differing Causes of Lactic Acidosis and Deep Breathing in Cerebral Malaria and Severe Malarial Anemia May Explain Differences in Acidosis-Related Mortality. PLoS One. 2016; 11(9):e0163728. Brand NR, Opoka RO, Hamre KE, John CC. PMID: 27684745.
      View in: PubMed   Mentions: 4     Fields:    
    12. Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells. J Interferon Cytokine Res. 2015 Nov; 35(11):888-900. Onabajo OO, Porter-Gill P, Paquin A, Rao N, Liu L, Tang W, Brand N, Prokunina-Olsson L. PMID: 26134097.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    13. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013 Feb; 45(2):164-71. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. PMID: 23291588.
      View in: PubMed   Mentions: 355     Fields:    Translation:HumansCells
    14. Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy. Cardiology. 1978; 63(6):337-42. Chandraratna PA, Langevin E, O'Dell R, Rubenstein C, San Pedro S. PMID: 100219.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    Nathan's Networks
    Concepts (84)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _